HOUSE OF REPRESENTATIVES

THE TWENTY-THIRD LEGISLATURE

REGULAR SESSION OF 2005

COMMITTEE ON CONSUMER PROTECTION AND COMMERCE

Rep. Kenneth T. Hiraki, Chair

Rep. Brian Schatz, Vice Chair

Rep. Kirk Caldwell

Rep. Scott Saiki

Rep. Robert N. Herkes

Rep. Alex Sonson

Rep. Ken Ito

Rep. Joseph M. Souki

Rep. Ezra R. Kanoho

Rep. Barbara C. Marumoto

Rep. Hermina M. Morita

Rep. Bud Stonebraker

COMMITTEE ON HEALTH

Rep. Dennis A. Arakaki, Chair

Rep. Josh Green, M.D., Vice Chair

Rep. Rida T.R. Cabanilla

Rep. Alex M. Sonson

Rep. Helene H. Hale

Rep. Lynn Finnegan

Rep. Scott Y. Nishimoto

COMMITTEE ON HUMAN SERVICES

Rep. Alex M. Sonson, Chair

Rep. Rida T.R. Cabanilla, Vice Chair

Rep. Dennis A. Arakaki

Rep. Bertha C. Kawakami

Rep. Josh Green, M.D.

Rep. Lynn Finnegan

Rep. Helène H. Hale

Rep. Bud Stonebraker

Rep. Michael Puamamo Kahikina

NOTICE OF HEARING

DATE:

Thursday, January 27,2005

TIME:

8:30 A.M.

PLACE:

Conference Room 329

State Capitol

415 South Beretania Street

A G E N D A

HB 30

RELATING TO PRESCRIPTION DRUGS.

Authorizes the director of human services to use the federal supply schedule for the negotiation and purchase of brand name prescription drugs in connection with prescription drug programs administered by the State.

CPC/HLT/HUS, FIN

HB 31

RELATING TO PRESCRIPTION DRUGS.

Requires quarterly reports from manufacturers of prescription drugs dispensed in the State. The quarterly reports shall disclose the: average wholesale price; wholesale acquisition cost; average manufacturer price; and the best price.

CPC/HLT/HUS, JUD, FIN

HB 32

RELATING TO PRESCRIPTION DRUG COST CONTAINMENT AND AFFORDABLE ACCESS.

Requires drug manufacturers to disclose value and purpose of gifts or economic benefits of $25 or more that are provided to health care professionals in promotional or marketing activities; requires director to establish pharmacy best practices and cost control program and to implement program for medicaid and other state public assistance health benefits plans; establishes drug utilization review board; requires director to request section 1115 waiver to maximize federal participation in state drug programs.

CPC/HLT/HUS, JUD, FIN

 

DECISION MAKING TO FOLLOW

PERSONS WISHING TO TESTIFY ARE REQUESTED TO SUBMIT 40 COPIES OF THEIR TESTIMONY AT LEAST 24 HOURS PRIOR TO THE HEARING TO: (1) THE CPC COMMITTEE'S VICE CHAIR IN ROOM 425, STATE CAPITOL, OR (2) THE HOUSE SGT.-AT-ARMS TESTIMONY DROP OFF BOX IN THE TURNAROUND AREA OF THE CAPITOL BASEMENT PARKING LOT. TESTIMONY MAY ALSO BE FAXED IF LESS THAN 5 PAGES IN LENGTH TO THE HOUSE SGT.-AT-ARMS OFFICE AT: 586-6501 (OAHU) OR 1-800-535-3859 (NEIGHBOR ISLANDS). WHEN FAXING, PLEASE INDICATE TO WHOM THE TESTIMONY IS BEING SUBMITTED, THE DATE AND TIME OF THE HEARING, AND THE REQUIRED NO. OF COPIES THAT IS NEEDED FOR SUBMITTAL.

IT IS ALSO REQUESTED THAT THE COPIES BE ON ONE SIDE OF AN 8-1/2" X 11" SHEET.

ORAL TESTIMONY SHALL BE LIMITED TO THREE MINUTES. FOR FURTHER INFORMATION, PLEASE CALL THE CPC COMMITTEE CLERK AT 586-6180.

IF YOU REQUIRE SPECIAL ASSISTANCE OR AUXILIARY AIDS AND/OR SERVICES TO PARTICIPATE IN THE PUBLIC HEARING PROCESS OF THE STATE HOUSE (I.E., SIGN LANGUAGE INTERPRETER, WHEELCHAIR ACCESSIBILITY, OR PARKING DESIGNATED FOR THE DISABLED), PLEASE CONTACT THE COMMITTEE CLERK AT LEAST 24 HOURS PRIOR TO THE HEARING SO ARRANGEMENTS CAN BE MADE.

 

 

________________________________________

Rep. Dennis A. Arakaki

Chair

________________________________________

Rep. Kenneth Hiraki

Chair

________________________________________

Rep. Alex M. Sonson

Chair